Showing results (81-90 of 105) with videos related to
Sort By:
Pageof 11
Frontiers in Genetics|December 13, 2012
Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in SpainJosé A G Agúndez, Francisco Abad-Santos, Ana Aldea, et al.Pharmacological Research|November 27, 2016
Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish populationElena Ramírez, Teresa Bellón, Hoi Y Tong, et al.Trials|January 7, 2022
DUbbing Language-therapy CINEma-based in Aphasia post-Stroke (DULCINEA): study protocol for a randomized crossover pilot trialBlanca Fuentes, Lydia de la Fuente-Gómez, Cristian Sempere-Iborra, et al.Research and Practice in Thrombosis and Haemostasis|January 23, 2023
No changes in hemostasis after COVID-19-heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS studyNora V Butta, Elena G Arias-Salgado, Elena Monzón Manzano, et al.Journal of Clinical Medicine|July 2, 2021
Acenocoumarol Pharmacogenetic Dosing Algorithm versus Usual Care in Patients with Venous Thromboembolism: A Randomised Clinical TrialHoi Yan Tong, Alberto M Borobia, Manuel Quintana-Díaz, et al.Annals of Emergency Medicine|October 19, 2019
Inhaled Methoxyflurane Provides Greater Analgesia and Faster Onset of Action Versus Standard Analgesia in Patients With Trauma Pain: InMEDIATE: A Randomized Controlled Trial in Emergency DepartmentsAlberto M Borobia, Sergio García Collado, César Carballo Cardona, et al.Iscience|January 29, 2025
The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19Clara Hernández-Blanco, Karima Al-Akioui-Sanz, Lara Herrera, et al.Pharmaceutics|October 29, 2025
Analgesic Effect of a Novel Intravenous Ibuprofen-Low-Dose Tramadol Combination: A Multimodal Approach to Moderate-to-Severe Postoperative Dental PainM Rosario Salas-Butrón, Leonor Laredo-Velasco, Ana B Rivas-Paterna, et al.BMJ Open|November 7, 2024
Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trialStefan Stewart, Enrique Seco-Meseguer, Elena Diago-Sempere, et al.Clinical Lymphoma, Myeloma & Leukemia|February 21, 2021
Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL-Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic LeukemiaLara Maria Gómez García, Adela Escudero, Carmen Mestre, et al.Pageof 11